Cancer Epidemiology Biomarkers and Prevention This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
Conclusions: Histories of endometriosis; asthma; depression; osteoporosis; and autoimmune, gallbladder, kidney, liver, or neurologic diseases were not associated with ovarian cancer overall or progression-free survival. Impact: These previously diagnosed chronic diseases do not appear to affect ovarian cancer prognosis. Cancer Epidemiol Biomarkers Prev; 26(9); 1470–3. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Minlikeeva, A. N., Freudenheim, J. L., Eng, K. H., Cannioto, R. A., Friel, G., Szender, J. B., Segal, B., Odunsi, K., Mayor, P., Diergaarde, B., Zsiros, E., Kelemen, L. E., Köbel, M., Steed, H., deFazio, A., on behalf of the Australian Ovarian Can Tags: Null Results in Brief Source Type: research

Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study
Conclusions: Our results suggest that previously reported differences in breast cancer survival by genetic ancestry may be overcome by improving health care access and/or quality. Impact: Improving health care access and quality may reduce breast cancer disparities among U.S. Latinas. Cancer Epidemiol Biomarkers Prev; 26(9); 1466–9. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Engmann, N. J., Ergas, I. J., Yao, S., Kwan, M. L., Roh, J. M., Ambrosone, C. B., Kushi, L. H., Fejerman, L. Tags: Null Results in Brief Source Type: research

Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study
Conclusions: We did not detect any novel statistically significant exonic variants with overall breast cancer risk or by subtype. Impact: Exonic variants in the exome chip may not be associated with overall breast cancer or subtype susceptibility. Cancer Epidemiol Biomarkers Prev; 26(9); 1462–5. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Lacson, J. C. A., Ma, H., Lee, E., Neuhausen, S. L., Anton-Culver, H., Reynolds, P., Nelson, D. O., Ziogas, A., Van Den Berg, D., Deapen, D. M., Bernstein, L., Schumacher, F. R. Tags: Null Results in Brief Source Type: research

No Association of Vitamin D Pathway Genetic Variants with Cancer Risks in a Population-Based Cohort of German Older Adults
Conclusions: Our data provide little to no evidence of a major influence of vitamin D genetic predisposition on cancer risks. Impact: Large-scale genetic epidemiology consortia and meta-analysis of smaller published studies are needed to verify a potential modest influence of genetic variation in the association of vitamin D with the risk of cancer. Cancer Epidemiol Biomarkers Prev; 26(9); 1459–61. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Ordonez-Mena, J. M., Schöttker, B., Saum, K. U., Holleczek, B., Burwinkel, B., Wang, T. J., Brenner, H. Tags: Null Results in Brief Source Type: research

Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women
Conclusions: Age at menarche and late adolescent BMI are both associated with Cumulus measures of mammographic density on processed FFDM images. Impact: Age at menarche and late adolescent BMI may act through different pathways. The long-term effects of age at menarche on cancer risk may be mediated through factors besides mammographic density. Cancer Epidemiol Biomarkers Prev; 26(9); 1450–8. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Alexeeff, S. E., Odo, N. U., Lipson, J. A., Achacoso, N., Rothstein, J. H., Yaffe, M. J., Liang, R. Y., Acton, L., McGuire, V., Whittemore, A. S., Rubin, D. L., Sieh, W., Habel, L. A. Tags: Research Articles Source Type: research

Medical Care Cost of Oropharyngeal Cancer among Texas Patients
Conclusions: Medical care cost was about $140,000 in the first 2 years after diagnosis of oropharyngeal cancer among commercially insured patients in Texas. Impact: The cost estimates provide important parameters for development of decision-analytic models to inform decision makers about the potential value of initiatives for increasing the HPV immunization rate in the state. Cancer Epidemiol Biomarkers Prev; 26(9); 1443–9. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Lairson, D. R., Wu, C.-F., Chan, W., Dahlstrom, K. R., Tam, S., Sturgis, E. M. Tags: Research Articles Source Type: research

Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes
Conclusions: Taken together, we found that genetic variation of obesity-related genes could influence RCC susceptibility. Impact: The five identified loci may provide new insights into disease etiology that reveal importance of obesity-related genes in RCC development. Cancer Epidemiol Biomarkers Prev; 26(9); 1436–42. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Shu, X., Purdue, M. P., Ye, Y., Tu, H., Wood, C. G., Tannir, N. M., Wang, Z., Albanes, D., Gapstur, S. M., Stevens, V. L., Rothman, N., Chanock, S. J., Wu, X. Tags: Research Articles Source Type: research

Quantifying the Genetic Correlation between Multiple Cancer Types
Conclusions: Our results highlight novel genetic correlations and lend support to previous observational studies that have observed links between cancers and risk factors. Impact: This study demonstrates modest genetic correlations between cancers; in particular, breast, colorectal, and lung cancer share some degree of genetic basis. Cancer Epidemiol Biomarkers Prev; 26(9); 1427–35. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Lindström, S., Finucane, H., Bulik-Sullivan, B., Schumacher, F. R., Amos, C. I., Hung, R. J., Rand, K., Gruber, S. B., Conti, D., Permuth, J. B., Lin, H.-Y., Goode, E. L., Sellers, T. A., Amundadottir, L. T., Stolzenberg-Solomon, R., Klein, A., Pe Tags: Research Articles Source Type: research

How Many Deaths from Colorectal Cancer Can Be Prevented by 2030? A Scenario-Based Quantification of Risk Factor Modification, Screening, and Treatment in Norway
Conclusions: Risk factor modification, screening, and treatment all have considerable potential to reduce colorectal cancer mortality by 2030, with the largest potential reduction observed for improved treatment and risk factor modification. Impact: The estimation of these health impact measures provides useful information that can be applied in public health decision-making. Cancer Epidemiol Biomarkers Prev; 26(9); 1420–6. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Skyrud, K. D., Myklebust, T. A., Bray, F., Eriksen, M. T., de Lange, T., Larsen, I. K., Moller, B. Tags: Research Articles Source Type: research

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia
Conclusions: Fecal methylated SDC2 is a valuable biomarker for the noninvasive detection of colorectal neoplasms. Impact: Stool DNA test of methylated SDC2 would serve as an alternative method for screening colorectal neoplasms. Cancer Epidemiol Biomarkers Prev; 26(9); 1411–9. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Niu, F., Wen, J., Fu, X., Li, C., Zhao, R., Wu, S., Yu, H., Liu, X., Zhao, X., Liu, S., Wang, X., Wang, J., Zou, H. Tags: Research Articles Source Type: research

The Impact of a Population-Based Screening Program on Income- and Immigration-Related Disparities in Colorectal Cancer Screening
Conclusions: Introduction of a population-based screening program promoting FOBT for colorectal cancer was associated with only modest improvements in immigration and income-related disparities. Impact: Reducing immigration and income-related disparities should be a focus for future research and policy work. Disparities in Ontario seem to be driven by a higher uptake of colonoscopy among more advantaged groups. Cancer Epidemiol Biomarkers Prev; 26(9); 1401–10. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Kiran, T., Glazier, R. H., Moineddin, R., Gu, S., Wilton, A. S., Paszat, L. Tags: Research Articles Source Type: research

Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen
Conclusions: Colorectal cancer screening in NZ using FOBTi is likely to be cost-effective but risks increasing inequalities in health for Māori. Impact: To avoid or mitigate the generation of further health inequalities, attention should be given to underserved population groups when planning and implementing screening programs. Cancer Epidemiol Biomarkers Prev; 26(9); 1391–400. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: McLeod, M., Kvizhinadze, G., Boyd, M., Barendregt, J., Sarfati, D., Wilson, N., Blakely, T. Tags: Research Articles Source Type: research

The Association of Telomere Length in Peripheral Blood Cells with Cancer Risk: A Systematic Review and Meta-analysis of Prospective Studies
The association between telomere length (TL) in peripheral blood cells and cancer risk remains inconclusive. We carried out a meta-analysis on prospective studies. The study-specific RR estimates were first transformed to a common comparable scale and then were pooled by a random-effects model. The dataset was composed of 13,894 cases and 71,672 controls from 28 studies in 25 articles. In the comparison of the longest versus shortest third of TL, we observed a marginally positive association between longer TL and higher risk of total cancers [OR = 1.086; 95% confidence interval (CI), 0.952–1.238]. Subgroup analyses s...
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Zhang, X., Zhao, Q., Zhu, W., Liu, T., Xie, S.-H., Zhong, L.-X., Cai, Y.-Y., Li, X.-N., Liang, M., Chen, W., Hu, Q.-S., Zhang, B. Tags: Reviews Source Type: research

Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
In conclusion, new high-dimensional exposure assessments offer many new opportunities for environmental assessment in cancer development. Cancer Epidemiol Biomarkers Prev; 26(9); 1370–80. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Patel, C. J., Kerr, J., Thomas, D. C., Mukherjee, B., Ritz, B., Chatterjee, N., Jankowska, M., Madan, J., Karagas, M. R., McAllister, K. A., Mechanic, L. E., Fallin, M. D., Ladd-Acosta, C., Blair, I. A., Teitelbaum, S. L., Amos, C. I. Tags: Reviews Source Type: research

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium
This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations. Cancer Epidemiol Biomarkers Prev; 26(9); 1360–9. ©2017 AACR. (Source: Cancer Epidemiology Biomarkers and Prevention)
Source: Cancer Epidemiology Biomarkers and Prevention - August 31, 2017 Category: Cancer & Oncology Authors: Nichols, H. B., Schoemaker, M. J., Wright, L. B., McGowan, C., Brook, M. N., McClain, K. M., Jones, M. E., Adami, H.-O., Agnoli, C., Baglietto, L., Bernstein, L., Bertrand, K. A., Blot, W. J., Boutron-Ruault, M.-C., Butler, L., Chen, Y., Doody, M. M., Dos Tags: Reviews Source Type: research